NPI: 1114989787
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,803 | $165K |
| 2019 | 7,645 | $161K |
| 2020 | 3,234 | $140K |
| 2021 | 925 | $43K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | 6,812 | 5,245 | $455K | |
| 99214 | 547 | 473 | $27K | |
| 99203 | 199 | 154 | $13K | |
| 99394 | 91 | 80 | $7K | |
| 99393 | 48 | 41 | $4K | |
| 99212 | 17 | 12 | $1K | |
| 36416 | 2,590 | 1,945 | $297.85 | |
| 36415 | 1,217 | 1,018 | $285.23 | |
| 85025 | 3,358 | 2,537 | $217.83 | |
| 96372 | 432 | 333 | $93.78 | |
| 99173 | 99 | 84 | $93.78 | |
| 87804 | 298 | 225 | $89.88 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 73 | 52 | $67.82 |
| 87880 | 1,505 | 1,174 | $34.01 | |
| 99000 | 221 | 188 | $4.45 | |
| 90471 | 247 | 175 | $0.00 | |
| 92551 | 93 | 78 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 37 | 28 | $0.00 |
| 90686 | 20 | 14 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 14 | 12 | $0.00 |
| 81003 | 635 | 520 | $0.00 | |
| J0945 | Injection, brompheniramine maleate, per 10 mg | 37 | 28 | $0.00 |
| 90472 | 17 | 16 | $0.00 |